Showing results (1-10 of 24) with videos related to

Sort By:
Pageof 3
Journal of Interferon & Cytokine Research : the Official Journal of the International Society for Interferon and Cytokine Research|October 22, 2008
A biosensor-based characterization of the affinity maturation of the immune response against interferon-beta and correlations with neutralizing antibodies in treated multiple sclerosis patientsEbrima Gibbs, Joel Oger
Journal of Neuroimmunology|September 11, 2007
The IgG subclass-specificities of anti-IFNbeta antibodies change with time and differ between the IFNbeta products in relapsing remitting multiple sclerosis patientsEbrima Gibbs, Joel Oger
Clinical Immunology (Orlando, Fla.)|December 28, 2014
Antibody dissociation rates are predictive of neutralizing antibody (NAb) course: a comparison of interferon beta-1b-treated Multiple Sclerosis (MS) patients with transient versus sustained NAbsEbrima Gibbs, Mohammad Ehsanul Karim, Joel Oger, et al.
Journal of Neuroimmunology|June 13, 2006
During 3 years treatment of primary progressive multiple sclerosis with glatiramer acetate, specific antibodies switch from IgG1 to IgG4Erika Basile, Ebrima Gibbs, Tariq Aziz, et al.
Canadian Journal of Ophthalmology. Journal Canadien D'Ophtalmologie|October 8, 2017
Antigen-specificity of antiretinal antibodies in patients with noninfectious uveitisEbrima Gibbs, Joanne Matsubara, Sijia Cao, et al.
Vaccine|July 21, 2019
Therapeutic vaccines for amyotrophic lateral sclerosis directed against disease specific epitopes of superoxide dismutase 1Beibei Zhao, Kristen Marciniuk, Ebrima Gibbs, et al.
Statistical Methods in Medical Research|April 13, 2021
A method for systematically ranking therapeutic drug candidates using multiple uncertain screening criteriaXubiao Peng, Ebrima Gibbs, Judith M Silverman, et al.
Journal of Immunological Methods|May 31, 2008
Validating parameters of a luciferase reporter gene assay to measure neutralizing antibodies to IFNbeta in multiple sclerosis patientsRegina Lam, Rachel Farrell, Tariq Aziz, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|December 25, 2025
Drug DevelopmentLarry D Altstiel, Misty Lamendola, Wendy Luca, et al.
ACS Chemical Neuroscience|July 17, 2023
De Novo Design of a β-Helix Tau Protein Scaffold: An Oligomer-Selective Vaccine Immunogen Candidate for Alzheimer's DiseaseAdekunle Aina, Shawn C C Hsueh, Ebrima Gibbs, et al.
Pageof 3